Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

BioLineRx (BLRX) Cost of Revenue: 2012-2024

Historic Cost of Revenue for BioLineRx (BLRX) over the last 13 years, with Dec 2024 value amounting to $23.6 million.

  • BioLineRx's Cost of Revenue fell 98.88% to $72,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $11.0 million, marking a year-over-year decrease of 61.63%. This contributed to the annual value of $23.6 million for FY2024, which is 6.59% down from last year.
  • According to the latest figures from FY2024, BioLineRx's Cost of Revenue is $23.6 million, which was down 6.59% from $25.3 million recorded in FY2023.
  • In the past 5 years, BioLineRx's Cost of Revenue ranged from a high of $25.3 million in FY2023 and a low of $840,000 during FY2020.
  • In the last 3 years, BioLineRx's Cost of Revenue had a median value of $23.6 million in 2024 and averaged $18.4 million.
  • Per our database at Business Quant, BioLineRx's Cost of Revenue surged by 544.27% in 2022 and then fell by 6.59% in 2024.
  • Over the past 5 years, BioLineRx's Cost of Revenue (Yearly) stood at $840,000 in 2020, then rose by 19.40% to $1.0 million in 2021, then surged by 544.27% to $6.5 million in 2022, then spiked by 291.06% to $25.3 million in 2023, then decreased by 6.59% to $23.6 million in 2024.